This report was first published by Endpoints News. To see the original version, click here
Kintsugi promised to use AI as a screening tool to detect signs of depression and anxiety in people’s voices during routine doctors’ appointments, backed by high-profile investors like Insight Partners.
It delivered, publishing peer-reviewed studies and running pilot programs in hospitals. But then it shut down. Instead of selling the company, it released its research to the public.
您已阅读14%（474字），剩余86%（2893字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。